Tirzepatide is a once-weekly dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. As a synthetic peptide with a C18 fatty diacid moiety enabling albumin binding, tirzepatide demonstrates prolonged half-life characteristics ideal for sustained research applications. It has been extensively studied in clinical trials for its effects on glycemic control and body composition metrics. Our tirzepatide is synthesized to pharmaceutical-grade specifications and independently certified for purity.
For Research Use Only. This product is not intended for human or veterinary use, diagnostic, or therapeutic purposes. It must not be used as a food, drug, or cosmetic. By adding to cart you confirm you are a qualified researcher using this product in compliance with all applicable laws.
Secure checkout with Cash App, Zelle, or Bitcoin.
All products for research use only.